Verification of the Ventana Anti-ALK (D5F3) Antibody in the Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer

被引：0
|
作者：
Narine, Nadira
Rana, Durgesh
机构：
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.086
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
086
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [41] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [42] Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement
    Kwon, Ji-Hyun
    Kim, Kui-Jin
    Sung, Ji Hea
    Suh, Koung Jin
    Lee, Ji Yun
    Kim, Ji-Won
    Kim, Se Hyun
    Lee, Jeong-Ok
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Kim, Soyeon
    Yoon, Sung-Soo
    Lee, Jong Seok
    CELLS, 2019, 8 (12)
  • [43] The Biology and Clinical Features of Non-small Cell Lung Cancers with EML4-ALK Translocation
    Pillai, Rathi N.
    Ramalingam, Suresh S.
    CURRENT ONCOLOGY REPORTS, 2012, 14 (02) : 105 - 110
  • [44] Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
    Lo Russo, Giuseppe
    Imbimbo, Martina
    Corrao, Giulia
    Proto, Claudia
    Signorelli, Diego
    Vitali, Milena
    Ganzinelli, Monica
    Botta, Laura
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina Chiara
    ONCOTARGET, 2017, 8 (35) : 59889 - 59900
  • [45] ALK rearrangement in non-small cell lung cancer
    Naulleau, Gaspard
    Birsen, Gary
    Mansuet-Lupo, Audrey
    Leroy, Karen
    Wislez, Marie
    BULLETIN DU CANCER, 2025, 112 (03) : 3S86 - 3S94
  • [46] Non-small Cell Lung Cancer Patients with EML4-ALK Fusion Gene Are Insensitive to Cytotoxic Chemotherapy
    Morodomi, Yosuke
    Takenoyama, Mitsuhiro
    Inamasu, Eiko
    Toyozawa, Ryo
    Kojo, Miyako
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Taguchi, Kenichi
    Seto, Takashi
    Sugio, Kenji
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (07) : 3825 - 3830
  • [47] Evaluation of EML4-ALK Fusion Proteins in Non-Small Cell Lung Cancer Using Small Molecule Inhibitors
    Li, Yongjun
    Ye, Xiaofen
    Liu, Jinfeng
    Zha, Jiping
    Pei, Lin
    NEOPLASIA, 2011, 13 (01): : 1 - U14
  • [48] FISH patterns of ROS1, MET, and ALK with a correlation of ALK immunohistochemistry in lung cancer: a case for introducing ALK immunohistochemistry 'Equivocal' interpretation category in the Ventana anti-ALK (D5F3) CDx assay - A tertiary cancer center experience
    Singh, Angad
    Kumar, Rajiv
    Shetty, Omshree
    Desai, Sangeeta
    Rane, Swapnil
    INDIAN JOURNAL OF CANCER, 2022, 59 (01) : 18 - +
  • [49] EML4-ALK fusion gene in resected non-small-cell lung cancer
    Takahashi, Tsuyoshi
    Sonobe, Makoto
    Menju, Toshi
    Nakayama, Ei
    Mino, Nobuya
    Iwakiri, Shotaro
    Sato, Kiyoshi
    Miyahara, Ryo
    Okubo, Kenichi
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S483 - S484
  • [50] Prognostic versus predictive value of EML4-ALK translocation in metastatic non-small cell lung cancer
    Shaw, A. T.
    Yeap, B.
    Costa, D. B.
    Solomon, B. J.
    Kwak, E. L.
    Nguyen, A. T.
    Bergethon, K.
    Engelman, J. A.
    Iafrate, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345